Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
04/2014
04/03/2014WO2014016707A3 Compositions comprising injectable biomaterial cement and radiopacity-improving agent
04/03/2014WO2013048558A3 Methods of therapeutic monitoring of nitrogen scavenging drugs
04/03/2014US20140094698 Cavity filling biopsy site markers
04/03/2014US20140093559 Abuse-proofed dosage form
04/03/2014US20140093458 In vivo selection of therapeutically active antibodies
04/03/2014US20140093456 Tumor model system useful to study multistage cancer
04/03/2014US20140093455 Method for treating and confirming diagnosis of exertional compartment syndrome
04/03/2014US20140093453 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
04/03/2014US20140093452 Magnetic Resonance Imaging Cell Labeling Methods and Compositions
04/02/2014EP2712627A2 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
04/02/2014CN103695370A Tumor cell line with tolerance to anti-angiogenesis treatment and establishing method and application thereof
04/02/2014CN103695000A Gadolinium doped zinc oxide nano particles and preparation method thereof
04/02/2014CN103694268A Kinase activity probe and method for treating related diseases
04/02/2014CN103690971A Superparamagnetic particles targeting rheumatoid arthritis part as well as preparation method and application of particles
04/02/2014CN102580120B Targeted magnetic resonance imaging (MRI) contrast agent and preparation method thereof
04/02/2014CN102552105B Cascade brain-targeting drug delivery system as well as preparation method and application thereof
04/02/2014CN102181397B Laryngeal squamous cell carcinoma cartilage invasion model
04/02/2014CN102043892B A molding and using method for a bulk drug gastrointestinal absorption prediction BSPK model
04/01/2014US8685441 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
04/01/2014US8685415 Mycobacterium mutants for vaccines with improved protective efficacy
04/01/2014US8685372 Peptides and aptamers for targeting of neuron or nerves
04/01/2014US8685371 Agents for detecting and imaging cell death
04/01/2014US8685370 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
04/01/2014US8685369 Technetium- and rhenium-bis (heteroaryl) complexes, and methods of use thereof
04/01/2014US8685367 Inherently radiopaque polymeric products for embolotherapy
04/01/2014CA2645946C Inhibitors of protein aggregation
04/01/2014CA2567478C Labelled adrenomedullin derivatives and their use for imaging and therapy
04/01/2014CA2423122C Closure of bacterial ghosts
03/2014
03/27/2014WO2014046807A1 Hydrophobic shielding for enhanced nanoparticle stability
03/27/2014WO2014046490A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
03/27/2014WO2014046478A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
03/27/2014WO2014046423A1 Peptide having cancer selective translocation function and use thereof
03/27/2014WO2014044916A1 Chelates, chelating agents, conjugates derived thereof and their use
03/27/2014WO2013112643A8 Low density, highly porous nano structure
03/27/2014US20140090095 Genetically Modified Mice and Engraftment
03/27/2014US20140090094 Modulators of slc22a7
03/27/2014US20140088418 Functional-imaging-based ablation monitoring
03/27/2014US20140086846 Contrast enhancement agents and method of use thereof
03/27/2014US20140086845 Method for imaging a site of arthritis in an animal
03/27/2014US20140086844 Luminescent compounds
03/27/2014US20140086843 Bifunctional hydroxy-bisphosphonic acid derivatives
03/27/2014US20140086842 Screening methods using g-protein coupled receptors and related compositions
03/27/2014US20140086841 Pig for atrioventricular block model, monkey for atrioventricular block model, guinea pig for atrioventricular block model, and use thereof
03/27/2014US20140086840 Therapeutic Antibody Target Validation and Screening In Vivo
03/27/2014US20140086838 Identification of a new molecular factor for early diagnosis of urothelial carcinoma of the bladder
03/27/2014US20140086835 Methods and Compositions for Heptameric Targeting Ligands
03/27/2014US20140086828 Modified gold nanoparticles for therapy
03/27/2014DE102012217301A1 Kombination aus Kontrastmittel und Mammographie-CT-System mit vorgegebenem Energiebereich und Verfahren zur Erzeugung tomographischer Mammographie-CT-Aufnahmen durch diese Kombination Combination of contrast medium and mammography CT system with a given energy and process for producing tomographic mammography CT images with this combination
03/26/2014EP2709674A1 A process for delivering encapsulated neutral bioimaging molecules, complex, and process thereof
03/26/2014CN103687854A Carbonic anhydrase targeting agents and methods of using same
03/26/2014CN103667326A Identification of group of hypertension-susceptibility genes
03/26/2014CN103663570A Method for preparing ovarian cancer target ferroferric oxide nano-particle at room temperature
03/26/2014CN103656691A Preparation method of ultrasonic/fluorescent bimodal microcapsule contrast medium
03/26/2014CN103656690A Method for preparing manganese chloride oral solution
03/26/2014CN103656689A Diagnosis kit for rapidly determining sensitivity of Aphis citricola to bifenthrin, and use method thereof
03/26/2014CN103656688A Optimal screening method of pharmaceutical preparation
03/26/2014CN103656687A Application of NRG (neuregulin) 1beta1/ErbB4/Akt signal pathway in preparing or screening drug target for resisting Alzheimer disease neuronal loss
03/26/2014CN103656686A Soluble marker for slow transfer experiment
03/26/2014CN103656669A Compound micelle-based nano-vector, and preparation method and application thereof
03/26/2014CN103656668A Bortezomib sustained-release preparation and preparation method thereof
03/26/2014CN103656638A Interleukin-1 alpha abs and methods of use
03/26/2014CN103656621A Novel mouse nerve growth factor intravitreal injection drug delivery system and application thereof
03/26/2014CN103027897B Method for preparing monodispersity hydrophobic drug nanoparticles by template method
03/26/2014CN102816125B Contrast agent
03/25/2014US8679460 Low osmolar X-ray contrast media formulations
03/25/2014US8679457 Metabolite biomarkers to distinguish Crohn's disease from ulcerative colitis and methods using the same
03/25/2014US8679456 Method of hyperpolarising a magnetic resonance agent
03/25/2014US8679454 Particle immobilized coatings and uses thereof
03/25/2014US8679453 Contrast agents
03/25/2014CA2585983C Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
03/25/2014CA2445826C Treatment and diagnosis of macrophage mediated disease
03/20/2014WO2014043677A2 Magnetic resonance imaging cell labeling methods and compositions
03/20/2014WO2014041563A1 Synergistic anti-cancer composition and a process for the preparation thereof
03/20/2014WO2014041546A1 Diagnostic agents with enhanced sensitivity/specificity
03/20/2014WO2014041150A1 Contrast agent and its use for imaging
03/20/2014WO2014041087A1 Muscle secretome and uses thereof
03/20/2014US20140082758 Control and Characterization of Psychotic States
03/20/2014US20140081133 System and methods for providing real-time anatomical guidance in a diagnostic or therapeutic procedure
03/20/2014US20140081015 Metallation enhancements in tumor-imaging and pdt therapy
03/20/2014US20140080997 Novel mite allergen
03/20/2014US20140079644 Cellulose-based nanoparticles for drug delivery
03/20/2014US20140079642 Nanoparticles based for dermal and systemic delivery of drugs
03/20/2014US20140079641 Imaging agents for use in magnetic resonance blood flow/perfusion imaging
03/20/2014US20140079640 Novel treatment of pain
03/20/2014US20140079638 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
03/20/2014US20140079637 Methods and compositions for improving antiangiogenic therapy with anti-integrins
03/20/2014US20140079632 Activity-based probes for the urokinase plasminogen activator
03/20/2014US20140079631 Anti-inflammatory particles
03/20/2014US20140079630 Carbon nanotubes for imaging and drug delivery
03/19/2014EP2708561A2 Bio-pin
03/19/2014EP2708244A1 Contrast agent and its use for imaging.
03/19/2014EP2707034A1 Activity-based probes for the urokinase plasminogen activator
03/19/2014CN103642491A Strong signal and low toxicity composite nanometer material and preparation method thereof
03/19/2014CN103638536A Molecular probe and preparation method and application thereof
03/19/2014CN103638535A B ultrasound coupling agent containing traditional Chinese components
03/19/2014CN103638534A Nanometer lipid ultrasonic contrast agent and preparation method thereof
03/19/2014CN103638533A Preparation method of magnetic nanorod with targeted HIF (hypoxia inducible factor) low toxicity
03/19/2014CN103638532A Gadolinium oxide targeted magnetic resonance contrast agent
03/19/2014CN103638531A LGR4 gene for screening of medicines promoting browning of white fat
03/19/2014CN103637854A Rabbit portal vein thrombosis model
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 354